Addressing Challenges in Cancer Care & Capacity Building | Global Oncology Symposium | City of Hope

Session #3
"Addressing Challenges and Unmet Needs in Global Cancer Care and Capacity Building"

04:06 Vijay Trisal, M.D. - "Second Opinion for Cancer Without Boundaries"
26:29 Lesley Taylor, M.D. - "The City of Hope-Ethiopia Breast Cancer Initiative: Strengthening global oncology research, education and care"

Vijay Trisal, M.D., Chief Medical Officer, Dr. Norman & Melinda Payson Professor in Medicine, City of Hope.
Lesley Taylor, M.D., Assistant Clinical Professor, Division of Breast Surgery, Department of Surgery, City of Hope.
Session Chair: I. Benjamin Paz, M.D., Vice Chair of Clinical Affairs, Department of Surgery, City of Hope.

City of Hope's Global Oncology Initiative aims to organize City of Hope clinicians, scientists, and educators and expand local and global partnerships to tackle current and impending challenges in Cancer and Global Health. As part of the initiative, the annual Global Oncology Symposium will cover a multitude of themes, employing conventional and unconventional formats to disseminate scientific findings, cancer control & prevention efforts to our communities and a global audience, and serve as the face of the initiative.

CONNECT WITH US

About City of Hope
City of Hope is an independent biomedical research and treatment center for cancer, diabetes and other life-threatening diseases. Founded in 1913, City of Hope is a leader in bone marrow transplantation and immunotherapy such as CAR T cell therapy. City of Hope’s translational research and personalized treatment protocols advance care throughout the world. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. A National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network, City of Hope is ranked among the nation’s “Best Hospitals” in cancer by U.S. News & World Report. Its main campus is located near Los Angeles, with additional locations throughout Southern California and in Arizona. Translational Genomics Research Institute (TGen) became a part of City of Hope in 2016. AccessHopeTM, a subsidiary launched in 2019, serves employers and their health care partners by providing access to NCI-designated cancer center expertise. For more information about City of Hope, follow us on Facebook, Twitter, YouTube or Instagram.